The RSV Beyfortus (Nirsevimab-alip) Monoclonal "Vaccine" Scam Is About To Explode! (Part 5)

RSV injuries are even worse than we are told...

Part 4: HERE

I don’t want to be coy about this assertion saying there is at least 96 more and 563 more 261 more “serious” injuries (reports) in VAERS, so I’m going to offer a free downloadable PDF and Excel Spreadsheet to all the VAERS hidden reports. Just click on image below to jump to my web page:

Click to launch

As you can see it’s thirteen pages in PDF viewable format, but there is a download button at upper right. There is also a button to download the Excel version at bottom right. The first column is the hyperlink that will launch you to each individual report in medalerts.org.

I have created quasi vaccine data for the monoclonals Synagis (Palivizumab) and Beyfortus (Nirsevimab) and added these line items to my master files so we can see that in the dashboard soon. Along with the regular RSV (Arexvy & Abrysvo) jabs that have gone unreported in VAERS. So much information is properly documented in the summary narrative section but VAERS doesn’t seem to ethically populate the data into missing data fields where applicable. I believe they are actively stripping data fields, but that’s another topic for now. The main dashboard is being updated as we speak, it will be live tomorrow. I did it this way because Substack doesn’t seem to like Excel spreadsheets, but handles PDF well. Moreover many people just aren’t excel folks or don’t want to pay Gill Bates. I don’t either, haven’t paid Gates for anything for about 15 years. Key gen activators baby, close the ports, don’t let your software report back to the mother ship! lol

I’ve been circling the wagon on FAERS which is basically the FDA’s version of VAERS. FDA wants you to believe it’s where they keep track of injuries to “drugs” as opposed to vaccines. My man Dr. Geoff Pain has been sniffing around FAERS and Remdesivir in his recent article.:

Remdesivir Deaths - was Endotoxin a factor?

The babies are being targeted with these monclonals that are not technically classified as vaccines, and they do not encourage the submitter to report an injury to VAERS unless it’s co-mingled with another vaxx on the same day and you want to be prudent and submit the Beyfortus info. The super big problem is that Beyfortus Monoclonal is not available to submitter on the regular pick list, so people are selecting UNKNOWN vax type, UNKNOWN MANFACTURER or not selecting anything at all but documenting in various free text fields like summary narrative, other medications filed, lab field, previous vaccination field, etc… The monoclonal injuries should wash out at FAERS. Like this:

Click to launch FDA FAERS Dashboard

The FAERS dashboard is pretty cool, and it actually has quite a few relevant views, but it also has some pros and cons. I had to manually cross walk some data into Excel to get some better visuals like this:

You can see this Palivizumab aka Synagis has 15,707 cases, 12,585 are serious and it includes 1,946 deaths dating back to 1998. You can also see there was a striking improvement to the data starting in 2020? I wonder what happened in 2020? The total cases doubled but the deaths kind of stayed the same? Some kind of shimmey-sham was probably activated beginning 2020 no doubt. I’m still not sure if kids are being targeted by two monoclonals Beyfortus and Synagis, or just Beyfortus alone? Per FAERS is looks like Synagis is still in play, but I’m not seeing that word in VAERS after 2022?

Something doesn’t add up with this Beyfortus and Synagis? Moreover, I just saw Michael Nevradakis updated his January Beyfortus article about French babies dying at a higher clip when Beyfortus was introduced there.

https://childrenshealthdefense.org/defender/newborns-rsv-shot-beyfortus-death-rate-france/

Here is what FAERS has on Beyfortus (Nirsevimab):

The fine print FAERS data says “Data as of December 31, 2023” but how is it they have 2024 data in FAERS already, and how often is the data set updated?

One other side note, it looks like Palivizumab (Synagis) is still available, but Nevradakis’ article said it was a “former equivalent drug”?

Click to launch

OMG what is going on? This reminds me of Three Card Monte between Sanofi, AstraZeneca, and now this Sobi. Stay alert folks, something is not according to Hoyle.

All Hidden Rsv Vaccines & Monoclonals 20240308

976KB ∙ PDF file

Download

Download

I don’t even want to bring up Motavizumab, another RSV thing that seemed to disappear like a fart in the wind circa ~2014? Nothing in FAERS for Motavizumab.

God Bless. Please support The Eagle!